Abstract:Background Duchenne Muscular Dystrophy (DMD) is an inherited neuromuscular degenerative disease that leaves muscle fibers more susceptible to mechanical stress due to muscle contraction, leading to progressive muscle weakness resulting in decreased lung ventilation and an ineffective cough, favoring the onset of complications such as respiratory failure, the main cause of mortality. Management of patients with DMD aims to maintain respiratory function and involves all aspects of care, including at home. Objective This study aims to investigate the effects of an optimal home-based respiratory care protocol in individuals with DMD. Methods This is a randomized, blinded controlled trial involving patients with DMD, aged 7 years. Patients will be randomly allocated into the conventional respiratory care (CRC) and optimized respiratory care home-based (ORC) groups. Primary outcomes will be peak cough flow and number of exacerbations. Secondary outcomes will include chest wall volumes, maximal respiratory pressures, nasal inspiratory and expiratory pressure and forced vital capacity (FVC), forced expiratory volume in the 1st second (FEV1) and, FEV1 /FVC. The CRC group will receive education on respiratory care during quarterly hospital visits will consist of guidelines on positioning in bed and during fluid and food ingestion. The caregiver will be trained on aspirating the oral cavity secretions and assisting patients in coughing through air stacking by manual ventilation with a bag and an oronasal mask when needed. The ORC group will receive education on respiratory care during quarterly hospital visits and weekly home visits by a physiotherapist. During the visit, the physiotherapist will provide settings to use and improve non-invasive ventilation, aspiration of upper airways and assisted coughing through air stacking. Both groups will receive weekly telephone calls to monitor patients and provide assistance to minimize complications and exacerbations. All caregivers will be trained to monitor vital signs and peripheral oxygen saturation. A 6-month intervention is planned, the outcomes will be assessed every 3 months, and 3- and 6-month follow-up after the final evaluation. Results The primary and secondary results will be described as average or median for continuous variables and absolute and relative frequencies for qualitative variables. Treatment effects or differences between the outcomes (baseline, 3 months, and 6 months) of the study groups will be analyzed using an analysis of variance. The level of significance will be set as p≤0.05. Conclusion individuals with DMD have respiratory complications that gradually worsen and may culminate in death. These patients should receive regular daily respiratory care and assistance from caregivers and family members, as well as professional follow-up to reduce exacerbations. The challenges associated with public health care for patients, as well as the lack of knowledge among health professionals and the community, favor the worsening of DMD and, consequently, the increase in hospitalizations and public spending. Implications We hope that the study can demonstrate the importance of home physiotherapy with specialized assistance, which will provide comfort and safety to patients and their families. We believe that a well-implemented therapeutic program will reduce morbidity and mortality rates in patients with DMD.

Purification of the scrapie agent by density gradient centrifugation.

Characteristics of associated reactions in people with hemiplegic cerebral palsy.

Problems in Child Neurology and Psychology

Age-related self-stigma of people over 65 years old: adaptation of the Internalized Stigma of Mental Illness scale (ISMI) for use in age-related self-stigma (IS65+) in a Spanish sample

Simulating Adaptive Quests for Increased Player Impact in MMORPGs

Factors Associated with Respiratory Health and Function in Duchenne Muscular Dystrophy: A Systematic Review and Evidence Grading

Transition and management of patients with Duchenne Muscular Dystrophy: a narrative review based on Italian experts' opinion and real-world experience

Alkyl-substituted thiolo-, thiono-, and dithio-gamma-butyrolactones: new classes of convulsant and anticonvulsant agents.

Respiratory function and therapeutic expectations in DMD: families experience and perspective

Respiratory comorbidities and treatments in Duchenne muscular dystrophy: impact on life expectancy and causes of death

Duchenne muscular dystrophy: an overview to the cardiologist

BREATHE DMD: boosting respiratory efficacy after therapeutic hypoxic episodes in Duchenne muscular dystrophy

Duchenne muscular dystrophy

Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis

EFFECTS OF NA OPTIMIZED APPROACH TO HOME-BASED RESPIRATORY CARE IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY: STUDY PROTOCOL FOR CLINICAL TRIAL

Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience

343VP Duchenne muscular dystrophy: the critical role of pulmonary infection in survival outcomes

A Multidisciplinary Evaluation of Patients with DMD in An Italian Tertiary Care Center

Sleep and sleep-related breathing disorders in patients with spinal muscular atrophy: a changing perspective from novel treatments?

Unveiling the Respiratory Muscle Strength in Duchenne Muscular Dystrophy: The Impact of Nutrition and Thoracic Deformities, Beyond Spirometry

Current Concepts in the Orthopaedic Management of Duchenne Muscular Dystrophy